[go: up one dir, main page]

MX2010012764A - Proceso para la preparacion de un componente intermedia para sintetizar un anticoagulante. - Google Patents

Proceso para la preparacion de un componente intermedia para sintetizar un anticoagulante.

Info

Publication number
MX2010012764A
MX2010012764A MX2010012764A MX2010012764A MX2010012764A MX 2010012764 A MX2010012764 A MX 2010012764A MX 2010012764 A MX2010012764 A MX 2010012764A MX 2010012764 A MX2010012764 A MX 2010012764A MX 2010012764 A MX2010012764 A MX 2010012764A
Authority
MX
Mexico
Prior art keywords
antiulcerant
synthesizing
intermediate compound
preparing intermediate
preparing
Prior art date
Application number
MX2010012764A
Other languages
English (en)
Inventor
Dong Yeon Kim
Jun Yeoun Lee
Kwi Hyung Cho
Sung Tae Park
Jung Woo Kim
Doo Hyuk Pyun
Sang Don Nam
Hee Yun Kim
Original Assignee
Il Yang Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41416876&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010012764(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Il Yang Pharm Co Ltd filed Critical Il Yang Pharm Co Ltd
Publication of MX2010012764A publication Critical patent/MX2010012764A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Lo divulgado es un método novedoso para preparar el compuesto representado por la Fórmula 3. Específicamente, el método divulgado es para preparar un intermedio de un antiulcerante, a través de una reacción del compuesto representado por la Fórmula 1 con el compuesto representado por la Fórmula 2: (ver fórmulas) En las cuales R representa C1-6 alquilo.
MX2010012764A 2008-06-12 2008-11-20 Proceso para la preparacion de un componente intermedia para sintetizar un anticoagulante. MX2010012764A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020080055111A KR101044880B1 (ko) 2008-06-12 2008-06-12 항궤양제 화합물의 합성에 유용한 중간체의 제조방법
PCT/KR2008/006849 WO2009151189A1 (en) 2008-06-12 2008-11-20 Process for preparing intermediate compound for synthesizing an antiulcerant

Publications (1)

Publication Number Publication Date
MX2010012764A true MX2010012764A (es) 2012-03-07

Family

ID=41416876

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010012764A MX2010012764A (es) 2008-06-12 2008-11-20 Proceso para la preparacion de un componente intermedia para sintetizar un anticoagulante.

Country Status (12)

Country Link
US (1) US20110071302A1 (es)
EP (1) EP2283010A4 (es)
JP (1) JP2011520873A (es)
KR (1) KR101044880B1 (es)
CN (1) CN101602758A (es)
BR (1) BRPI0822432B1 (es)
CL (1) CL2008003871A1 (es)
CO (1) CO6280533A2 (es)
MX (1) MX2010012764A (es)
MY (1) MY147894A (es)
TW (1) TW200951126A (es)
WO (1) WO2009151189A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101369584B1 (ko) 2011-04-19 2014-03-06 일양약품주식회사 페닐-이속사졸 유도체 및 그의 제조방법
CN113354623B (zh) * 2021-04-28 2024-04-05 上海高准医药有限公司 一种艾普拉唑关键中间体5-(1h-吡咯-1-基)-2-巯基苯并咪唑的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869554A (en) * 1972-04-21 1975-03-04 Int Flavors & Fragrances Inc Process for altering the flavoring properties of foodstuffs
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
ES512268A0 (es) * 1982-05-17 1984-05-16 Antibioticos Sa "procedimiento de obtencion de acidos alfa-n-pirrolil-derivados".
DE3869167D1 (de) * 1987-03-27 1992-04-23 Kumiai Chemical Industry Co Phenyltriazol-derivate und insectizid.
KR0179401B1 (ko) 1994-02-28 1999-03-20 송택선 신규한 5-피롤릴-2-피리딜메틸설피닐벤즈이미다졸 유도체
ES2212361T3 (es) * 1997-09-08 2004-07-16 Schering Aktiengesellschaft Derivados de benzoxazina y benzotiazina y su utilizacion en medicamentos.
ATE528301T1 (de) * 2005-03-25 2011-10-15 Livzon Pharmaceutical Group Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen
JP5130212B2 (ja) * 2006-07-07 2013-01-30 大日本住友製薬株式会社 光学活性3−アミノ−2,5−ジオキソピロリジン−3−カルボキシレート類およびその製造方法ならびに該化合物の使用

Also Published As

Publication number Publication date
CN101602758A (zh) 2009-12-16
KR20090129046A (ko) 2009-12-16
WO2009151189A1 (en) 2009-12-17
CO6280533A2 (es) 2011-05-20
EP2283010A4 (en) 2011-11-23
BRPI0822432A2 (pt) 2015-12-22
CL2008003871A1 (es) 2009-12-18
EP2283010A1 (en) 2011-02-16
TW200951126A (en) 2009-12-16
JP2011520873A (ja) 2011-07-21
MY147894A (en) 2013-01-31
BRPI0822432B1 (pt) 2020-07-07
US20110071302A1 (en) 2011-03-24
KR101044880B1 (ko) 2011-06-28

Similar Documents

Publication Publication Date Title
NZ734535A (en) Process of producing cycloalkylcarboxamido-indole compounds
WO2008089984A3 (en) Process for the preparation of ezetimibe and derivatives thereof
MY173940A (en) Process for producing pyrrole compound
IN2012DN02751A (es)
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
MY145818A (en) Process for producing ethylene
WO2008096372A3 (en) Process for preparing highly pure ezetimibe using novel intermediates
UA101835C2 (uk) Спосіб отримання похідних 1-(2-галогенбіфеніл-4-іл)-циклопропанкарбонової кислоти
PH12012501438A1 (en) Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
WO2010036329A3 (en) Process for making quinolone compounds
MX2009008196A (es) Nuevo procedimiento de sintesis de la agomelatina.
NZ586187A (en) Processes for the synthesis of sinomenine derivatives and their intermediate
MX357614B (es) Métodos para producir sales de viloxazina y polimorfos novedosos de las mismas.
PH12013500378A1 (en) Novel succinic acid-producing mutant microorganism that utilizes sucrose and glycerol simultaneously and method for producing succinic acid using the same
EP2452931A4 (en) PROCESS FOR THE PREPARATION OF TRICYCLIC DERIVATIVES
WO2009066735A1 (ja) 2-アザアダマンタン類の製造方法
WO2010058427A3 (en) Process for production and purification of polymyxin b sulfate
UA106988C2 (uk) Спосіб одержання 1-бензил-3-гідроксиметил-1h-індазолу і його похідних та необхідні проміжні сполуки магнію
PH12013500609A1 (en) Novel method of preparing benzoimidazole derivatives
MY147894A (en) Process for preparing intermediate compound for synthesizing an antiulcerant
MX2018010128A (es) Toxina nueva y metodo de preparacion de un intermediario de la misma.
WO2011057947A3 (en) Method for producing silicon
WO2014133291A9 (ko) (2rs)-아미노-(3s)-히드록시-부티르산 또는 이의 유도체의 제조방법
NZ589496A (en) Processes and compounds for the preparation of normorphinans
MY161959A (en) Continuous production of high purity carbon dioxide

Legal Events

Date Code Title Description
FG Grant or registration